FIELD: chemistry.
SUBSTANCE: invention relates to tetracyclic antibiotic anthraquinone derivatives having anticancer activity.
EFFECT: tetracyclic antibiotic anthraquinone derivatives described in the present invention have the same or higher activity than current medicinal agents such as doxorubicin, daunorubicin or similar, in a cellular level, and at the same time have better tolerance than doxorubicin and daunorubicin for animal organism.
15 cl, 54 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| THIOPHENE DERIVATIVES | 2010 |
|
RU2536865C2 |
| DERIVATIVES OF 2-SUBSTITUTED PHENYL-5,7-DIHYDROCARBYL-3,7-DIHYDROPYRROLO[2,3-d]PYRIMIDIN-4-ONES, THEIR PREPARING AND PHARMACEUTICAL USING | 2004 |
|
RU2323220C2 |
| HETEROCYCLIC COMPOUNDS AS TRK INHIBITORS | 2019 |
|
RU2803817C2 |
| HETEROCYCLIC COMPOUND USED AS A FGFR INHIBITOR | 2017 |
|
RU2742485C2 |
| CYANOQUINOLINE DERIVATIVES | 2011 |
|
RU2600928C2 |
| METHOD OF PRODUCING PHENOXYPYRIDINE DERIVATIVE | 2012 |
|
RU2590158C2 |
| SIMPLE METHOD OF PRODUCING AVIBACTAM | 2018 |
|
RU2711358C1 |
| INDANE CONDENSED DERIVATIVES, METHOD OF THEIR SYNTHESIS AND COMPOSITION SHOWING ANTITUMOR EFFECT | 1995 |
|
RU2124017C1 |
| QUINOLINE OR QUINAZOLINE DERIVATIVE USED AS AXL INHIBITOR | 2014 |
|
RU2666895C2 |
| DERIVATIVES OF AMINOSTILBAZOLE OR THEIR HYDRATES, OR THEIR SALTS AND PHARMACEUTICAL COMPOSITION BASED ON SAID | 1995 |
|
RU2138482C1 |
